Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Feb 24;21(1):121.
doi: 10.1186/s12891-020-3148-1.

The efficacy of continuous versus single-injection femoral nerve block in Total knee Arthroplasty: a systematic review and meta-analysis

Affiliations
Meta-Analysis

The efficacy of continuous versus single-injection femoral nerve block in Total knee Arthroplasty: a systematic review and meta-analysis

Hsuan-Hsiao Ma et al. BMC Musculoskelet Disord. .

Abstract

Background: Continuous femoral nerve block (cFNB) has been developed to extend the analgesic effect since the efficacy of single-injection femoral nerve block (sFNB) is often limited to approximately 16-24 h. The aim of this meta-analysis was to validate the add-on effect of cFNB in the setting of a multimodal analgesic protocol.

Methods: We performed a comprehensive literature review on Web of Science, Embase, the Cochrane Library and PubMed. Eight randomized controlled trials (N = 626) that compared the efficacy of cFNB with sFNB were included. The primary outcome domains consist of visual analog scale (VAS) score at postoperative 24 and 48 h. The secondary outcome domains include opioid consumption, length of hospital stay and incidence of nausea.

Results: Our analysis revealed that cFNB was associated with a lower VAS score at 24 h (SMD: -0.277;95% CI - 0.503 to - 0.05). However, the difference of VAS score did not meet the minimal clinically importance difference for total knee arthroplasty (TKA). VAS score at 48 h was similar between the cFNB and sFNB group. The cFNB group was associated with less amount of opioids consumed at both 24(SMD: -1.056;95% CI - 1.737 to - 0.375) and 48 h(SMD: -1.040;95% CI - 1.790 to - 0.289). Length of hospital stay and incidence of nausea were similar between the two groups.

Conclusion: In the setting of a multimodal analgesic protocol, patients might benefit from cFNB with regards to a reduced need of opioids in the early postoperative period. However, we did not find a clinically significant difference in pain scores at different time points between the cFNB and sFNB group.

Level of evidence: I; meta-analysis.

Keywords: Continuous; Femoral nerve block; Nerve block; Pain; Single-injection; Total knee arthroplasty.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Preferred reporting items for systematic reviews and meta-analysis (PRISMA) study flow diagram
Fig. 2
Fig. 2
Standardized mean difference (SMD) for VAS score at postoperative 24 h with continuous femoral nerve block (cFNB) versus single-injection femoral nerve block (sFNB)
Fig. 3
Fig. 3
Standardized mean difference (SMD) for VAS score at postoperative 48 h with continuous femoral nerve block (cFNB) versus single-injection femoral nerve block (sFNB)
Fig. 4
Fig. 4
Standardized mean difference (SMD) for total amount of opioids consumed at postopertaive 24 h with continuous femoral nerve block (cFNB) versus single-injection femoral nerve block (sFNB)
Fig. 5
Fig. 5
Standardized mean difference (SMD) for total amount of opioids consumed at postopertaive 48 h with continuous femoral nerve block (cFNB) versus single-injection femoral nerve block (sFNB)
Fig. 6
Fig. 6
Standardized mean difference (SMD) for length of hospital stay with continuous femoral nerve block (cFNB) versus single-injection femoral nerve block (sFNB)
Fig. 7
Fig. 7
Comparison of continuous femoral nerve block (cFNB) versus single-injection femoral nerve block (sFNB) with regard to postoperative nausea rate
Fig. 8
Fig. 8
Assessment of the risk of bias
Fig. 9
Fig. 9
Results of risk of bias evaluation for the included study

Similar articles

Cited by

References

    1. Soffin EM, YaDeau JT. Enhanced recovery after surgery for primary hip and knee arthroplasty: a review of the evidence. Br J Anaesth. 2016;117(suppl 3):iii62–iii72. doi: 10.1093/bja/aew362. - DOI - PubMed
    1. Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia" in postoperative pain treatment. Anesth Analg. 1993;77(5):1048–1056. doi: 10.1213/00000539-199311000-00030. - DOI - PubMed
    1. Parvizi J, Bloomfield MR. Multimodal pain management in orthopedics: implications for joint arthroplasty surgery. Orthopedics. 2013;36(2 Suppl):7–14. doi: 10.3928/01477447-20130122-51. - DOI - PubMed
    1. American Society of Anesthesiologists Task Force on Acute Pain M Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on acute pain management. Anesthesiology. 2012;116(2):248–273. doi: 10.1097/ALN.0b013e31823c1030. - DOI - PubMed
    1. Strassels SA, Chen C, Carr DB. Postoperative analgesia: economics, resource use, and patient satisfaction in an urban teaching hospital. Anesth Analg. 2002;94(1):130–137. - PubMed

MeSH terms